Biomarin Pharmaceutical Inc (BMRN)
91.22
-0.82
(-0.89%)
USD |
NASDAQ |
Apr 24, 16:00
87.90
-3.32
(-3.64%)
After-Hours: 19:56
Biomarin Pharmaceutical Total Return Level: 92.04 for April 23, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 23, 2024 | 92.04 |
April 22, 2024 | 89.49 |
April 19, 2024 | 88.63 |
April 18, 2024 | 90.07 |
April 17, 2024 | 90.47 |
April 16, 2024 | 90.87 |
April 15, 2024 | 91.51 |
April 12, 2024 | 92.22 |
April 11, 2024 | 91.46 |
April 10, 2024 | 90.21 |
April 09, 2024 | 88.98 |
April 08, 2024 | 87.28 |
April 05, 2024 | 86.95 |
April 04, 2024 | 86.89 |
April 03, 2024 | 86.78 |
April 02, 2024 | 86.80 |
April 01, 2024 | 87.10 |
March 28, 2024 | 87.34 |
March 27, 2024 | 88.61 |
March 26, 2024 | 87.74 |
March 25, 2024 | 86.52 |
March 22, 2024 | 85.13 |
March 21, 2024 | 84.11 |
March 20, 2024 | 84.76 |
March 19, 2024 | 85.27 |
Date | Value |
---|---|
March 18, 2024 | 83.81 |
March 15, 2024 | 83.87 |
March 14, 2024 | 84.39 |
March 13, 2024 | 84.77 |
March 12, 2024 | 85.18 |
March 11, 2024 | 86.00 |
March 08, 2024 | 85.95 |
March 07, 2024 | 85.89 |
March 06, 2024 | 86.77 |
March 05, 2024 | 86.02 |
March 04, 2024 | 87.72 |
March 01, 2024 | 87.14 |
February 29, 2024 | 86.28 |
February 28, 2024 | 88.40 |
February 27, 2024 | 90.68 |
February 26, 2024 | 90.10 |
February 23, 2024 | 91.24 |
February 22, 2024 | 89.97 |
February 21, 2024 | 88.54 |
February 20, 2024 | 88.67 |
February 16, 2024 | 88.77 |
February 15, 2024 | 88.30 |
February 14, 2024 | 86.01 |
February 13, 2024 | 86.13 |
February 12, 2024 | 88.18 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
64.27
Minimum
Oct 02 2019
131.03
Maximum
Jul 20 2020
86.85
Average
85.26
Median
Jul 26 2022
Total Return Level Benchmarks
Eli Lilly and Co | 2146.42 |
Merck & Co Inc | 426.26 |
Pfizer Inc | 89.95 |
Bristol-Myers Squibb Co | 196.03 |
Moderna Inc | 107.88 |